Literature DB >> 26215953

WEE1 Kinase As a Target for Cancer Therapy.

Sabine Mueller1, Daphne A Haas-Kogan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26215953     DOI： 10.1200/JCO.2015.62.2290

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

Review 1.  Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.

Authors:  Jessica S Brown; Brent O'Carrigan; Stephen P Jackson; Timothy A Yap
Journal:  Cancer Discov       Date:  2016-12-21       Impact factor: 39.397

2.  Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.

Authors:  Weizhen Liu; Xiangyu Zeng; Yuping Yin; Chengguo Li; Wenchang Yang; Wenze Wan; Liang Shi; Guobin Wang; Kaixiong Tao; Peng Zhang
Journal:  Gastric Cancer       Date:  2019-06-13       Impact factor: 7.370

3.  Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.

Authors:  Chang Shu; Qiong Wang; Xiaoling Yan; Jinhuan Wang
Journal:  J Mol Neurosci       Date:  2018-03-03       Impact factor: 3.444

Review 4.  The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality.

Authors:  S Percy Ivy; Johann de Bono; Elise C Kohn
Journal:  Trends Cancer       Date:  2016-11-23

5.  Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

Authors:  Shumei Kato; Nithya Krishnamurthy; Kimberly C Banks; Pradip De; Kirstin Williams; Casey Williams; Brian Leyland-Jones; Scott M Lippman; Richard B Lanman; Razelle Kurzrock
Journal:  Cancer Res       Date:  2017-06-22       Impact factor: 12.701

6.  Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study.

Authors:  Sabine Mueller; Tabitha Cooney; Xiaodong Yang; Sharmistha Pal; Ralph Ermoian; Amar Gajjar; Xiaowei Liu; Komal Prem; Charles G Minard; Joel M Reid; Marvin Nelson; Daphne Haas-Kogan; Elizabeth Fox; Brenda J Weigel
Journal:  Neurooncol Adv       Date:  2022-05-20

7.  Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.

Authors:  Daniel C Moreira; Sujatha Venkataraman; Apurva Subramanian; John Desisto; Ilango Balakrishnan; Eric Prince; Angela Pierce; Andrea Griesinger; Adam Green; Charles G Eberhardt; Nicholas K Foreman; Rajeev Vibhakar
Journal:  J Neurooncol       Date:  2020-03-16       Impact factor: 4.130

8.  Association between MicroRNA-373 and Long Noncoding RNA NORAD in Hepatitis C Virus-Infected Hepatocytes Impairs Wee1 Expression for Growth Promotion.

Authors:  Subhayan Sur; Reina Sasaki; Pradip Devhare; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

9.  Expression and clinical significance of Wee1 in colorectal cancer.

Authors:  Eivind Valen Egeland; Kjersti Flatmark; Jahn M Nesland; Vivi Ann Flørenes; Gunhild M Mælandsmo; Kjetil Boye
Journal:  Tumour Biol       Date:  2016-05-24

10.  Efficacy of adavosertib therapy against anaplastic thyroid cancer.

Authors:  Yu-Ling Lu; Yu-Tung Huang; Ming-Hsien Wu; Ting-Chao Chou; Richard J Wong; Shu-Fu Lin
Journal:  Endocr Relat Cancer       Date:  2021-04-29       Impact factor: 5.678
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.